MedTrace Logo

Study of Anaesthesia Costs and Recovery Profiles

NCT02920749 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-02-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the perioperative hemodynamic parameters, recovery profiles and cost containment of sevoflurane and propofol based general anesthesia for otorhinolaryngeal surgery.

Conditions

  • Anaesthesia

Interventions

DRUG

Sevoflurane group A

In this group anaesthesia was maintained with sevoflurane. Initial and maintenance fresh gas flow was 4 and 1 l/min, respectively. Sevoflurane dosing was adjusted for the same MAP range.

DRUG

Sevoflurane group B

In this group anaesthesia was maintained with sevoflurane. Initial and maintenance fresh gas flow was 4 and 1 l/min, respectively. Sevoflurane dosing was set to maintain target BIS levels of 40 to 60 and MAP for controlled hypotension within 60-85 mmHg.

DRUG

Propofol group C

In this group anaesthesia was maintained with propofol. Propofol was administered according to protocol. Propofol dosing was adjusted for the same MAP range.

DRUG

Propofol group D

In this group anaesthesia was maintained with propofol. Propofol dosing was set to maintain target BIS levels of 40 to 60 and MAP for controlled hypotension within 60-85 mmHg.

Sponsors & Collaborators

  • University of Pecs

    lead OTHER

Principal Investigators

  • Csaba Loibl, MD · Department of Anesthesiology and Intensive Therapy, University of Pecs, Hungary

  • Zoltan Vamos, MD, PhD · Department of Anesthesiology and Intensive Therapy, University of Pecs, Hungary

  • Gabor Woth, MD, PhD · Department of Anesthesiology and Intensive Therapy, University of Pecs, Hungary

  • Lajos Bogar, MD, PhD, DSc · Department of Anesthesiology and Intensive Therapy, University of Pecs, Hungary

  • Laszlo Lujber, MD, PhD · Department of Otorhinolaryngology, University of Pecs, Hungary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920749 on ClinicalTrials.gov